Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systane Complete for evaporative dry eye
ISRCTN10208997Phase 4Completed
- Sponsor
- Centro de la Visión
- Start
- Sep 2023
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propylene glycol-hydroxypropyl guar nanoemulsion in dry eye syndrome (DED), sponsored by Centro de la Visión. Primary endpoint: Dry eye symptoms at 3 months. Started Sep 2023; status: completed.
02
Drugs
propylene glycol-hydroxypropyl guar nanoemulsion
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ISRCTN10208997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10208997.